ITH: A Scalable, Community-based Program for War and Refugee Trauma

Sponsor
University of Washington (Other)
Overall Status
Recruiting
CT.gov ID
NCT05890482
Collaborator
Case Western Reserve University (Other)
200
2
2
31.6
100
3.2

Study Details

Study Description

Brief Summary

In low and middle-income countries, access to state-of-the-art mental health care is often limited. Islamic Trauma Healing (ITH) is a manualized mosque-based, lay-led group intervention aimed at healing the individual and communal mental wounds of war and refugee trauma. The investigators will execute a hybrid effectiveness-implementation randomized controlled trial (RCT) of ITH versus delayed ITH to evaluate mental health effectiveness and ease of implementation.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Islamic Trauma Healing
N/A

Detailed Description

Background: Somalia has long been in a state of humanitarian crisis; trauma-related mental health needs are extremely high. Access to state-of-the-art mental health care is limited. Islamic Trauma Healing (ITH) is a manualized mosque-based, lay-led group intervention aimed at healing the individual and communal mental wounds of war and refugee trauma. The 6-session intervention combines Islamic principles with empirically-supported exposure and cognitive restructuring principles for posttraumatic stress disorder (PTSD). ITH reduces training time, uses a train the trainers (TTT) model, and relies on local partnerships embedded within the strong communal mosque infrastructure.

Methods: The investigators will conduct a hybrid effectiveness-implementation randomized control trial (RCT) in the Somaliland, with implementation in the cities of Hargeisa, Borama, and Burao. In this study, a lay-led, mosque-based intervention, Islamic Trauma Healing (ITH), to promote mental health and reconciliation will be examined in 200 participants, randomizing mosques to either immediate ITH or a delayed (waitlist; WL) ITH conditions. Participants will be assessed by assessors masked to condition at pre, 3 weeks, 6 weeks, and 3 month follow-up. Primary outcome will be assessor-rated posttraumatic stress symptoms (PTSD), with secondary outcomes of depression, somatic symptoms, and well-being. A TTT model will be tested, examining the implementation outcomes. Additional measures include potential mechanisms of change and economic evaluation.

Conclusion: This trial has the potential to provide effectiveness and implementation data for an empirically-based principle trauma healing program for the larger Islamic community that may not seek mental health care or does not have access to such care.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Islamic Trauma Healing: A Scalable, Community-based Program for War and Refugee Trauma
Actual Study Start Date :
May 15, 2022
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Islamic Trauma Healing (ITH)

A lay-led, six-session group intervention that combines empirically supported exposure-based and cognitive restructuring techniques with Islamic principles.

Behavioral: Islamic Trauma Healing
Manualized, lay-led psychosocial intervention

Other: Wait List/Delayed (ITH)

Six week waitlist condition and then crossed-over to six weeks of the ITH intervention

Behavioral: Islamic Trauma Healing
Manualized, lay-led psychosocial intervention

Outcome Measures

Primary Outcome Measures

  1. PTSD Scale - Interview for the Diagnostic and Statistical Manual Version 5 [Change from pre to week 6 (immediate post intervention)]

    PTSD Severity, higher score worse severity, 0 to 80

Secondary Outcome Measures

  1. Patient Health Questionnaire-9 [Change from pre to week 6 (immediate post intervention)]

    Depression Severity, higher score worse severity, 0 to 27

  2. Somatic Symptoms Scale-8 [Change from pre to week 6 (immediate post intervention)]

    Somatic Symptom Severity, higher score worse severity, 0 to 32

  3. World Health Organization-5 Wellbeing Index [Change from pre to week 6 (immediate post intervention)]

    Quality of Well-Being, higher score better well-being, 0 to 25

Other Outcome Measures

  1. Session Fidelity Checklist [ITH Session 1 through Session 6]

    Session by session rating of adherence to the protocol, higher better, 0% to 100%, average items completed

  2. Implementation Outcome Measure [Immediately post ITH intervention]

    Acceptability, appropriateness, and feasibility, higher better, 1 to 5

  3. Client Services Satisfaction Questionnaire [Immediately post ITH intervention]

    Satisfaction with ITH, high score higher satisfaction, 5 to 20

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Experienced a DSM-5 Criterion A trauma at least 12 weeks ago

  • Report current re-experiencing or avoidance PTSD symptoms

  • Islamic faith

  • 18-70 years of age

Exclusion Criteria:
  • Immediate suicide risk, with intent or plan

  • Cannot understand consent/visible cognitive impairment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Somaliland Youth Development and Voluntary Organization Burao Somalia
2 University of Burao Burao Somalia

Sponsors and Collaborators

  • University of Washington
  • Case Western Reserve University

Investigators

  • Principal Investigator: Norah C Feeny, PhD, Case Western Reserve University
  • Principal Investigator: Jacob A Bentley, PhD, University of Washington
  • Principal Investigator: Lori A Zoellner, PhD, University of Washington

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Lori Zoellner, Professor: Psychology, University of Washington
ClinicalTrials.gov Identifier:
NCT05890482
Other Study ID Numbers:
  • STUDY00015447
  • R2HC #70165
First Posted:
Jun 6, 2023
Last Update Posted:
Jun 6, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jun 6, 2023